Literature DB >> 20623201

Characterization of human embryonic stem cell-derived hematopoietic progenitor phenotype.

Hai-Yang Zhou1, Xiao-Yi Yang, Li-Jian Tao, Yue-Tian Chang, Ru-Ping Dai.   

Abstract

Differentiation of human embryonic stem cells (hESCs) into hematopoietic lineages using various methods has been reported. However, the phenotype that precisely defines the hematopoietic progenitor compartment with clonogenic activities has yet to be determined. Here, we measured and characterized progenitor function of subfractions of cells prospectively isolated from human embryoid bodies (hEBs) during hematopoietic differentiation basing on surface markers CD45, CD34, CD43, and CD38. We report that hematopoietic progenitors predominantly resided in the CD45(+) subset. CD43(+) cells lacking CD45 expression were largely devoid of progenitor activity. However, progenitor activity and multipotentiality was more enriched in CD45(+) cells co-expressing CD43. CD45(+) subset co-expressing CD34 but lacking CD38 expression (CD45(+)CD34(+)CD38(-)) were further enriched for CFU capacity compared to the CD45(+)CD34(+)CD38(+) subset. Our study demonstrates a role of CD43 in enriching hematopoietic progenitors derived from hEBs and reveals a hierarchical organization of hESC-derived hematopoietic progenitor compartments defined by phenotypic markers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623201     DOI: 10.1007/s11626-010-9337-8

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  9 in total

1.  Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties.

Authors:  Lisheng Wang; Li Li; Farbod Shojaei; Krysta Levac; Chantal Cerdan; Pablo Menendez; Tanya Martin; Anne Rouleau; Mickie Bhatia
Journal:  Immunity       Date:  2004-07       Impact factor: 31.745

2.  Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures.

Authors:  Maxim A Vodyanik; James A Thomson; Igor I Slukvin
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

3.  Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells.

Authors:  Parul Trivedi; Peiman Hematti
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

4.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

Authors:  M Bhatia; J C Wang; U Kapp; D Bonnet; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells.

Authors:  Kristin Chadwick; Lisheng Wang; Li Li; Pablo Menendez; Barbara Murdoch; Anne Rouleau; Mickie Bhatia
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

6.  Hematopoietic colony-forming cells derived from human embryonic stem cells.

Authors:  D S Kaufman; E T Hanson; R L Lewis; R Auerbach; J A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

7.  Feeder-free growth of undifferentiated human embryonic stem cells.

Authors:  C Xu; M S Inokuma; J Denham; K Golds; P Kundu; J D Gold; M K Carpenter
Journal:  Nat Biotechnol       Date:  2001-10       Impact factor: 54.908

8.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

9.  Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential.

Authors:  Maxim A Vodyanik; Jack A Bork; James A Thomson; Igor I Slukvin
Journal:  Blood       Date:  2004-09-16       Impact factor: 22.113

  9 in total
  1 in total

1.  Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.

Authors:  Judi A Sgambato; Tea Soon Park; Diana Miller; Leelamma M Panicker; Ellen Sidransky; Yu Lun; Ola Awad; Søren M Bentzen; Elias T Zambidis; Ricardo A Feldman
Journal:  Stem Cells Transl Med       Date:  2015-06-10       Impact factor: 6.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.